SLXN · Categories · Form 4
SLXN - SEC Form 4 insider transactions
Silexion Therapeutics Corp (SLXN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for SLXN
- SEC Form 4 filed by Shirvan Mitchell4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Noy Shlomo was granted 9,091 units of Ordinary Shares (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Alon Ruth was granted 9,091 units of Ordinary Shares, increasing direct ownership by 800% to 10,228 units (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- CSO and CDO Shirvan Mitchell was granted 49,726 units of Ordinary Shares, increasing direct ownership by 5,069% to 50,707 units (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- CFO and Secretary Horenshtein Hadar Mirit was granted 49,726 units of Ordinary Shares, increasing direct ownership by 11,840% to 50,146 units (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Chairman and CEO Hadar Ilan was granted 64,350 units of Ordinary Shares, increasing direct ownership by 5,740% to 65,471 units (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Abramov Dror Yosef was granted 9,091 units of Ordinary Shares, increasing direct ownership by 835% to 10,180 units (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Peled Amnon was granted 7,576 units of Ordinary Shares, increasing direct ownership by 1,146% to 8,237 units (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Lushi Avner was granted 9,091 units of Ordinary Shares (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Levin Ilan disposed of 5,550 units of Ordinary Shares and was granted 450,000 units of Ordinary Shares (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Abramov Dror Yosef was granted 794 units of Ordinary Shares (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Alon Ruth was granted 794 units of Ordinary Shares (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Noy Shlomo was granted 1,587 units of Ordinary Shares (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Lushi Avner was granted 1,587 units of Ordinary Shares (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)
- Director Peled Amnon was granted 661 units of Ordinary Shares (SEC Form 4)4 - Silexion Therapeutics Corp (0002022416) (Issuer)